This report provides exclusive insights into the COVID-19 impact on the Tuberculosis Diagnostics Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Tuberculosis Diagnostics Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Tuberculosis Diagnostics Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on tuberculosis diagnostics market provides in-depth analysis of segments and sub-segments in global as well as regional tuberculosis diagnostics market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional tuberculosis diagnostics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global tuberculosis diagnostics market. According to the report the global tuberculosis diagnostics market is projected to grow at a CAGR of 4.5% over the forecast period of 2018-2024.
Tuberculosis (TB) is the infectious bacterial disease caused by the mycobacterium tuberculosis bacteria. TB generally affects the lungs but it may affect the other part of the body. This mycobacterium tuberculosis bacteria can be transmitted into the air when a person affected with TB coughs, sneezes or spits, laughs or talks.
According to WHO, tuberculosis (TB) is one of the top 10 causes of death worldwide and in 2016, 10.4 million people fell ill with TB, and 1.7 million died from the disease (including 0.4 million among people with HIV). Over 95% of TB deaths occur in low and middle-income countries. All over the world, the occurrence of TB is rising to very rapidly which drive the growth of TB diagnostic market.
Rising geriatric population, and more advanced diagnostic methods such as Interferon-gamma release assay, and cytokine detection assay and treatment option are some factors driving the growth of Tuberculosis Diagnostic market worldwide. On the other side, the high cost associated with the Tuberculosis diagnosis tests is hampering the market growth. The various government and other private organizations are focusing on the prevention of TB. The rising awareness about the TB among the populations is likely to boost the growth of TB diagnostics market in the near future. Furthermore, the ongoing research and development to produce cost-effective and efficient TB diagnosis methods, which in turn can create more opportunities for the players operating in the tuberculosis diagnosis market in upcoming years.
Among the region, Asia-Pacific dominates the market of TB diagnostic market. India accounts for the largest share of the TB diagnostic market. According to the TB report 2017 released by world health organization (WHO), India continued to have the highest number of tuberculosis (TB) cases in the world. The undeveloped healthcare infrastructure in the Asia-Pacific countries highly contributes to the market growth of TB Diagnostic market in the Asia-Pacific region. North America and Europe are expected to grow at the moderate CAGR over the forecast period.
The report on global tuberculosis diagnostics market covers segments such as test type. On the basis of test type, the global tuberculosis diagnostics market is categorized into radiographic methods, nucleic acid testing, laboratory methods, drug-susceptibility testing, mantoux test (TST) and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-Pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global tuberculosis diagnostics market such as Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., BioMerieux SA, Hain Lifescience GmbH, Hologic Corporation, Abbott Laboratories, Alere, Inc, Siemens, Cepheid, and others.
provides deep insights on demand forecasts, market trends, and micro and macro
indicators. In addition, this report provides insights into the factors that
are driving and restraining the global tuberculosis diagnostics market.
Moreover, IGR-Growth Matrix analysis given in the report brings insight into
the investment areas that existing or new market players can consider. The
report provides insights into the market using analytical tools such as
Porter's five forces analysis and DRO analysis of tuberculosis diagnostics
market. Moreover, the study highlights current market trends and provides
forecast from 2018-2024. We also have highlighted future trends in the
tuberculosis diagnostics market that will impact the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
insight into the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the tuberculosis diagnostics
market to understand the present and future trends in this market and formulate
their strategies accordingly.